Back to Search
Start Over
Silver Products for Medical Indications: Risk-Benefit Assessment
- Source :
- Journal of Toxicology: Clinical Toxicology. 34:119-126
- Publication Year :
- 1996
- Publisher :
- Informa UK Limited, 1996.
-
Abstract
- Legitimate medicinal use of silver-containing products has dramatically diminished over the last several decades. Recently, however, some manufacturers have begun to enthusiastically promote oral colloidal silver proteins as mineral supplements and for prevention and treatment of many diseases. Indiscriminate use of silver products can lead to toxicity such as argyria.To assist health care professionals in a risk versus benefit assessment of over-the-counter silver-containing products, we herein examine the following issues: historical uses, chemistry, pharmacology, clinical toxicology, case reports of adverse events in the literature, and the recent promotion of over-the-counter silver products. Other sources of silver exposure (including environmental and dietary) and EPA exposure standards are discussed. A list of currently available silver products is provided for easy reference and screening.We emphasize the lack of established effectiveness and potential toxicity of these products.
- Subjects :
- Male
medicine.medical_specialty
Injury control
business.industry
Accident prevention
Health, Toxicology and Mutagenesis
Treatment outcome
Silver Compounds
Poison control
macromolecular substances
Silver Proteins
Toxicology
Argyria
Risk Assessment
Treatment Outcome
medicine
Animals
Humans
Female
Maximum Allowable Concentration
Intensive care medicine
business
Risk assessment
Subjects
Details
- ISSN :
- 07313810
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Toxicology: Clinical Toxicology
- Accession number :
- edsair.doi.dedup.....a42ffcc2e6313fff3e54361baa240b14
- Full Text :
- https://doi.org/10.3109/15563659609020246